Search the Newsreel

Hims & Hers Health raises 2023 revenue outlook after strong Q2 growth despite margin drop

Bausch Health Stock Gains Momentum as Stronger Earnings, Raised Outlook and Debt Progress Lift Investor Optimism

Usana Health Sciences | 10-Q: Q2 2026 Earnings Report

This document is the Q2 2026 Earnings Report (10-Q filing) for Usana Health Sciences. It contains the complete financial and operational disclosures for the second quarter of 2026 as required by regulatory bodies.

UBS Adjusts Price Target on Acadia Healthcare to $1.50 From $4.50, Keeps Neutral Rating

UBS has adjusted its price target for Acadia Healthcare (referred to as Accendra Health in the article) to $1.50, down from $4.50, while maintaining a Neutral rating on the stock. This adjustment follows similar downgrades and price target reductions from other firms like Citigroup …

Are Investors Undervaluing Tenet Healthcare (THC) Right Now?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in …

Is American Healthcare REIT, Inc. (AHR) Outperforming Other Finance Stocks This Year?

The Finance group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is American Healthcare REIT (AHR) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the …

HCA Healthcare (HCA) Stock May Be 49% Undervalued As Wage Pressure Builds

HCA Healthcare (HCA) stock appears significantly undervalued according to both Discounted Cash Flow (DCF) and P/E ratio analyses, despite a 75.1% return over the past five years. The valuation gap could be influenced by recent concerns over rising labor costs, staffing pressures, and leadership …

Why Did Oscar Health (OSCR) Fall After Record Profit and a Guidance Hike?

Oscar Health, Inc. (NYSE:OSCR) shares closed 11.9% lower at $26.54 on August 6, even after the insurer reported its most profitable first half and raised its full-year outlook. Second-quarter revenue rose 70% year over year to $4.88 billion, while the company swung to net …

New Century Healthcare Flags Bank Account Freeze Linked to Partner Probe

Tenet Healthcare Corporation (THC) Hits Fresh High: Is There Still Room to Run?

Shares of Tenet Healthcare (THC) have been strong performers lately, with the stock up 34.1% over the past month. The stock hit a new 52-week high of $270.57 in the previous session. Tenet has gained 34.4% since the start of the year compared to …

AMN Healthcare Services (NYSE:AMN) Stock Price Expected to Rise, Citizens Jmp Analyst Says

Cohen & Steers (OHI) discloses 7.85% Omega Healthcare stake via 23.4M shares

Cohen & Steers, through its investment management subsidiaries, has disclosed a beneficial ownership of 23,382,961 shares of Omega Healthcare Investors, Inc. common stock, representing 7.85% of the class. The firm and its subsidiaries hold sole voting power over 18,559,089 shares and sole dispositive power …

Clover Health Is Proving Its Profit Model (NASDAQ:CLOV)

AlphaMena Upgrades Dallah Healthcare to Buy Rating

Zacks Research Cuts Earnings Estimates for Molina Healthcare

Carry Wealth Raises Share Placing Price to Boost Expansion Funding

Carry Wealth Sets August Board Meeting to Review Interim Results and Dividend

NewEdge Advisors LLC Buys 26,945 Shares of Omega Healthcare Investors, Inc. $OHI

NewEdge Advisors LLC significantly increased its stake in Omega Healthcare Investors (NYSE:OHI) by 81% in the first quarter, acquiring an additional 26,945 shares to bring its total holding to 60,190 shares, valued at $2.64 million. Omega Healthcare Investors reported strong Q1 earnings with EPS …

Should agilon health’s (AGL) Profit Rebound and Higher Guidance Prompt a Fresh Look From Investors?

agilon health (AGL) reported a significant profit rebound in Q2 2026, swinging from a net loss to a net income of US$17.96 million, and raised its full-year revenue guidance. This improvement, driven by better medical cost management rather than just top-line growth, suggests a …

Citizens raises Omada Health stock price target on revenue growth

Citizens has increased its price target for Omada Health Inc (OMDA) to $32.00 from $27.00, maintaining a Market Outperform rating, due to strong revenue growth and raised EBITDA estimates. The firm now projects 2026 revenue at $338 million and 2027 revenue at $395 million, …

National Health Investors, Inc. (NYSE:NHI) Receives Consensus Recommendation of "Moderate Buy" from Analysts

National Health Investors, Inc. (NYSE:NHI) has received a "Moderate Buy" consensus recommendation from eight brokerages, with an average 12-month price target of $83.86, significantly higher than its current share price of $71.23. The company also reported strong quarterly earnings of $1.19 EPS on $121.32 …

Does Clover’s Profit Turn and Raised 2026 Guidance Reshape the Bull Case for CLOV?

Clover Health Investments, Corp. has already reported its second-quarter 2026 results, posting revenue of US$743.17 million versus US$477.62 million a year earlier and moving from a net loss of US$10.58 million to net income of US$28 million. Alongside this shift to profitability, the company …

USANA (USNA) Q2 2026 Earnings Call Transcript

Tenet Signs CAD$225M Minimum Guarantee Annual Services Agreement

Toronto, Ontario--(Newsfile Corp. - August 14, 2026) - Tenet Fintech Group Inc. (CSE: PKK) (OTC Pink: PKKFF) ("Tenet" or the "Company"), an innovative analytics service provider, owner and operator of the Cubeler Business Hub, today announced that it has signed an agreement with Sum …

Deutsche Bank Adjusts Aveanna Healthcare PT to $16 From $11.50, Maintains Buy Rating

Deutsche Bank has increased its price target for Aveanna Healthcare Holdings Inc. (AVAH) to $16 from $11.50, while reiterating a Buy rating on the stock. This adjustment reflects an updated outlook from the bank regarding the company's valuation. Earlier the same day, UBS also …

Fractyl Health Eyes Q4 Revita Data, Launches Rejuva Gene Therapy Trial

Fractyl Health is anticipating key data in Q4 for its Revita treatment, an endoscopic procedure aimed at preventing weight regain after GLP-1 assisted weight loss. The company is also launching a clinical trial for Rejuva, a gene therapy designed to induce pancreatic beta cells …

Numans Health Food Signals Higher Profit on Lower Revenue in Supplemental Alert

China Tian Yuan Healthcare Schedules Board Meeting on Interim Results and Dividend

Cosmos Health Inc expected to post earnings of 1 cent a share - Earnings Preview

Cosmos Health Inc is anticipated to report earnings of 1 cent per share. This article provides an earnings preview for the company. Access to the full Reuters article is available through a TradingView subscription.

Raymond James raises Aveanna Healthcare stock price target on strong results

Raymond James raised its price target on Aveanna Healthcare Holdings (NASDAQ:AVAH) to $15.00 from $13.00, maintaining a Strong Buy rating due to strong Q2 2026 results and an increased EBITDA guidance. The company also reported Q2 2026 revenue of $670.5 million, exceeding analyst forecasts, …

Distinct Healthcare Holdings (SEHK:2677) Stock Looks Cheap Until One Off Gains Fade

China Healthwise Sets August Board Meeting to Review Interim Results and Dividend

Fortis Healthcare shares gain 2.52%, trades at Rs 929.00

Primary Health Properties (LON:PHP) Price Target Raised to GBX 133

Should I Buy GUTS (Fractyl Health, Inc. Common Stock) | AI Analysis, Technical & News Insights

Sinohealth Technology Sets Board Meeting to Review Interim Results and Consider Dividend